NEUROENDOCRINE TUMORS
Clinical trials for NEUROENDOCRINE TUMORS explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE TUMORS trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First-in-Human trial tests 'Off-the-Shelf' cell therapy for Tough-to-Treat cancers
Disease control Not yet recruitingThis is the first time a new cell therapy called NEUK203-13 Injection is being tested in people. The study aims to see if it is safe and can help control tumors in patients with advanced small cell lung cancer or other neuroendocrine tumors that have stopped responding to standar…
Matched conditions: NEUROENDOCRINE TUMORS
Phase: PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New radioactive drug enters human testing for Hard-to-Treat tumors
Disease control Not yet recruitingThis is the first human study of an experimental radioactive drug called RYZ401 for people with advanced neuroendocrine tumors and other solid tumors that have a specific marker. The main goals are to find the safest and most effective dose, check for side effects, and see if the…
Matched conditions: NEUROENDOCRINE TUMORS
Phase: PHASE1 • Sponsor: RayzeBio, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New scan aims to sharpen the picture for Hard-to-Spot tumors
Diagnosis Not yet recruitingThis study is testing a new type of PET scan to see if it can better find and map out neuroendocrine tumors. The goal is to help doctors more accurately locate tumors, plan treatments, and predict how patients will do. It will enroll 152 people who are diagnosed with or suspected…
Matched conditions: NEUROENDOCRINE TUMORS
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Diagnosis
Last updated Mar 27, 2026 12:38 UTC
-
National hunt for clues on rare Cancer-Related heart damage
Knowledge-focused Not yet recruitingThis study aims to gather information on patients with carcinoid heart disease, a rare condition where a type of cancer causes scarring and damage to heart valves. Researchers will look at the medical records of about 120 patients to understand who gets this complication, how it …
Matched conditions: NEUROENDOCRINE TUMORS
Sponsor: National Institute of Cardiology, Warsaw, Poland • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC